# Neera K. Dahl

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/neera-k-dahl/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,509 |
| Field | Genetic and Kidney Cyst Diseases |
| h-index | 21 |
| i10-index | 43 |
| Last Known Institution | Mayo Clinic |
| OpenAlex ID | https://openalex.org/A5035061312 |
| ORCID iD | 0000-0001-5809-9961 |
| Works | 120 |

## Researcher papers

- [Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/atrasentan-and-renal-events-in-patients-with-type-2-diabetes-and-chronic-kidney/)
- [A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan](https://scholariq.org/papers/a-practical-guide-for-treatment-of-rapidly-progressive-adpkd-with-tolvaptan/)
- [Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management](https://scholariq.org/papers/extra-renal-manifestations-of-autosomal-dominant-polycystic-kidney-disease-adpkd/)
- [The AE gene family of Cl/HCO3- exchangers.](https://scholariq.org/papers/the-ae-gene-family-of-cl-hco3-exchangers/)
- [Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial](https://scholariq.org/papers/impact-of-primary-kidney-disease-on-the-effects-of-empagliflozin-in-patients/)
- [Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial](https://scholariq.org/papers/effects-of-empagliflozin-on-progression-of-chronic-kidney-disease-a-prespecified/)
- [The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease](https://scholariq.org/papers/the-clinical-utility-of-genetic-testing-in-the-diagnosis-and-management-of/)
- [Evaluation of urine biomarkers of kidney injury in polycystic kidney disease](https://scholariq.org/papers/evaluation-of-urine-biomarkers-of-kidney-injury-in-polycystic-kidney-disease/)
- [Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy](https://scholariq.org/papers/total-kidney-volume-in-autosomal-dominant-polycystic-kidney-disease-a-biomarker/)
- [Advancing Genetic Testing in Kidney Diseases: Report From a National Kidney Foundation Working Group](https://scholariq.org/papers/advancing-genetic-testing-in-kidney-diseases-report-from-a-national-kidney/)
- [Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry](https://scholariq.org/papers/pain-and-health-related-quality-of-life-in-autosomal-dominant-polycystic-kidney/)

## Researcher topics

- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Kidney Stones and Urolithiasis Treatments](https://scholariq.org/topics/kidney-stones-and-urolithiasis-treatments/)
- [Genetic Syndromes and Imprinting](https://scholariq.org/topics/genetic-syndromes-and-imprinting/)

## Researcher university

- [Mayo Clinic](https://scholariq.org/institutions/mayo-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.